2024
Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9—Pragmatic Research and Innovation through Multinational Experimentation
Omerovic E, Petrie M, Redfors B, Fremes S, Murphy G, Marquis-Gravel G, Lansky A, Velazquez E, Perera D, Reid C, Smith J, van der Meer P, Lipsic E, Juni P, McMurray J, Bauersachs J, Køber L, Rouleau J, Doenst T. Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9—Pragmatic Research and Innovation through Multinational Experimentation. Trials 2024, 25: 80. PMID: 38263138, PMCID: PMC10807265, DOI: 10.1186/s13063-024-07935-y.Peer-Reviewed Original ResearchConceptsRandomized controlled trialsValue-based health careHealth policy decision-makingResearch priority settingQuality of healthcareHealthcare delivery systemValue-based healthcareDiverse practice settingsEffectiveness of interventionsPragmatic clinical trialsDiverse patient populationsPublic health impactEvidence-based medicineHealthcare qualityHealth outcomesHealth careHealthcare settingsDecision-making questionsPractice settingsPriority settingDecision-makingAlternative interventionsHealthcareStudy designPRCTs
2023
Equity in Modifying Plaque of Women With Undertreated Calcified Coronary Artery Disease: The EMPOWER CAD Study Design and Rationale
Lansky A, McEntegart M. Equity in Modifying Plaque of Women With Undertreated Calcified Coronary Artery Disease: The EMPOWER CAD Study Design and Rationale. Cardiovascular Revascularization Medicine 2023, 53: s14. DOI: 10.1016/j.carrev.2023.05.029.Peer-Reviewed Original ResearchCRT-101.06 Equity in Modifying Plaque of Women With Undertreated Calcified Coronary Artery Disease: The EMPOWER CAD Study Design and Rationale
Lansky A, McEntegart M. CRT-101.06 Equity in Modifying Plaque of Women With Undertreated Calcified Coronary Artery Disease: The EMPOWER CAD Study Design and Rationale. JACC Cardiovascular Interventions 2023, 16: s4. DOI: 10.1016/j.jcin.2023.01.031.Peer-Reviewed Original Research